Summary:
A clinical research study evaluating the safety and effectiveness of an investigational drug designed to lower cholesterol, specifically low-density lipoprotein cholesterol (LDL-C), known as the harmful or “bad” form of cholesterol.
Have a family history of high cholesterol and/or history of cardiovascular disease such as coronary artery disease (CAD), peripheral artery disease (PAD), and/or cerebrovascular disease.
You are 18 years of age or older and have elevated “bad” cholesterol levels:
• Fasting LDL-C of 100 mg/dL (2.6 mmol/L) or greater
OR
• Fasting LDL-C of 55 mg/dL (1.8 mmol/L) to 100 mg/dL (2.6 mmol/L) with at least 1 of the following risk factors:
Recent heart attack (about 3 months ago to less than 1 year);
Type 2 diabetes;
Other blood test results such as fasting triglycerides greater than150mg/dL (1.7mmol/L), fasting lipoprotein (a) greater than 30 mg/dL (70 nmol/L), or fasting HDL-C less than 40 mg/dL (1.0 mmol/L) (the “good” form of cholesterol).
You are taking medication(s) to lower cholesterol (if applicable) such as statin(s).
• You may be eligible if you are taking a low dose of statin medication, no statin medication (due to intolerance), or a combination of cholesterol-lowering medications.
Qualified Participants May Receive:
Study related exams and medications. $100 per completed visit.